Results 231 to 240 of about 7,203,816 (245)

Pharmacokinetic and pharmacodynamic properties of long-acting insulin analogue NN304 in comparison to NPH insulin in humans

Experimental and Clinical Endocrinology and Diabetes, 2000
Thomas Pieber, M Ellmerer
exaly  

Time-action profile of the soluble, fatty acid acylated, long-acting insulin analogue NN304

Diabetic Medicine, 1999
Lutz Heinemann, T Heise, C Weyer
exaly  

Comparative efficacy and safety of long-acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta-analyses

Journal of Diabetes Investigation, 2012
Daizhi Yang, Yuantao Hao, Hua Liang
exaly  

Association Between the Use of Long-Acting Insulin and Hypoglycemia in Nondiabetic Patients in the Surgical Intensive Care Unit.

Journal of Intensive Care Medicine, 2018
Christopher Alan Giuliano
exaly  

Long-acting Insulin: Slow Release of Insulin from a Biodegradable Matrix Implanted in Diabetic Rats

Diabetes, 1983
Mattheus F A Goosen, Anthony M Sun, G M O'Shea   +2 more
exaly  

Long-acting Insulin Analogues and Diabetic Retinopathy: A Retrospective Cohort Study

Clinical Therapeutics, 2014
Mei-shu Lai, Jen-Chieh Lin
exaly  

A long-term analysis evaluating the cost-effectiveness of biphasic insulin lispro mix 75/25 and mix 50/50 versus long-acting basal insulin analogs in the United States

Journal of Medical Economics, 2012
Richard F Pollock, William J Valentine
exaly  

Willingness to Pay for Improvements in Chronic Long-Acting Insulin Therapy in Individuals With Type 1 or Type 2 Diabetes Mellitus

Clinical Therapeutics, 2011
Simon Heller, Andrew Lloyd, Mette Bøgelund   +2 more
exaly  

Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir

Current Medical Research and Opinion, 2006
exaly  

The Long Acting Human Insulin Analog HOE 901: Characteristics of Insulin Signalling in Comparison to Asp(B10) and Regular Insulin

Hormone and Metabolic Research, 1998
L Berti, B Bossenmaier, M Kellerer
exaly